✦ LIBER ✦

Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: A validation study

✍ Scribed by Jason W. Bauer; Michelle Petri; Franak M. Batliwalla; Thearith Koeuth; Joseph Wilson; Catherine Slattery; Angela Panoskaltsis-Mortari; Peter K. Gregersen; Timothy W. Behrens; Emily C. Baechler

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 451 KB
Volume: 60
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.24803

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reticulocytes bearing C4d as biomarkers

Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus

✍ Chau-Ching Liu; Susan Manzi; Amy H. Kao; Jeannine S. Navratil; Margie J. Ruffing 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB 👁 1 views

Serum free light chains as biomarkers fo

Serum free light chains as biomarkers for systemic lupus erythematosus disease activity

✍ Rohit Aggarwal; Winston Sequeira; Rediet Kokebie; Rachel A. Mikolaitis; Lewis Fo 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 267 KB 👁 2 views

## Abstract ## Objective To evaluate serum free light chains (FLC) as a putative biomarker of systemic lupus erythematosus (SLE) activity. ## Methods Seventy‐five SLE patients and 41 age‐ and sex‐matched rheumatoid arthritis (RA) controls were enrolled. Disease activity was assessed using the Sa

Activation of the interferon-α pathway i

Activation of the interferon-α pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease

✍ Kyriakos A. Kirou; Christina Lee; Sandhya George; Kyriakos Louca; Margaret G. E. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

## Abstract ## Objective Gene‐expression studies have demonstrated increased expression of interferon (IFN)–inducible genes (IFIGs) in peripheral blood mononuclear cells (PBMCs) of many patients with systemic lupus erythematosus (SLE), with a predominant effect of type I IFN. This study examined t

Longitudinal study of the impact of inci

Longitudinal study of the impact of incident organ manifestations and increased disease activity on work loss among persons with systemic lupus erythematosus

✍ Edward Yelin; Chris Tonner; Laura Trupin; Stuart A. Gansky; Laura Julian; Patric 📂 Article 📅 2012 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 105 KB 👁 2 views

Systemic lupus erythematosus in a multie

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients

✍ Jaime Calvo-Alén; Sergio M. A. Toloza; Mónica Fernández; Holly M. Bastian; Barri 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

## Abstract ## Objective Venous thrombosis is a relatively frequent and serious complication in systemic lupus erythematosus (SLE) that has been associated with the presence of antiphospholipid antibodies (aPL). However, venous thrombotic events can also be seen in patients without aPL, and only a

Elevated triglycerides and low levels of

Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor α/tumor necrosis factor receptor system in systemic lupus erythematosus

✍ Elisabet Svenungsson; Iva Gunnarsson; Guo-Zhong Fei; Ingrid E. Lundberg; Lars Kl 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views